LoValTech is a mucosal platform that will revolutionize vaccination.
LoValTech has raised $5.3M in total funding. The most recent round was Grant. The last funding was announced in July 2023.
LoValTech's investors include France 2030.
LoValTech is headquartered in Val-de-roulans, France.
LoValTech is a mucosal platform that will revolutionize vaccination.
LoValTech is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"LoValTech — Funding & Investors." VCBacked, July 25, 2023, https://www.vcbacked.co/company/lovaltech. Accessed August 15, 2026.
VCBacked. (2023). LoValTech — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/lovaltech
{{cite web |title=LoValTech — Funding & Investors |url=https://www.vcbacked.co/company/lovaltech |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated